Offices of Biotechnology and Business Development

Overview

Welcome to the Offices of Biotechnology and Business Development's website.
********************************************************** 

                                                    ***ATTENTION RESEARCH COMMUNITY!!***  

The Discovery Fast Track Challenge from the Discovery Partnerships with Academia (DPAc) group at GlaxoSmithKline (“GSK”) is announcing a call for proposals with the goal of discovering new pharmacologically active molecules via High Throughput Screening (HTS) and/or Encoded Library Technology (ELT).  For successful applicants, this will help drive their research forward and could lead to a partnership with GSK for the development of a new medicine.  

  

Up to twenty projects, ten from Europe and ten from North America, will be selected in the 2014 challenge.  If you are interested in applying for this collaborative opportunity, a one-page non-confidential proposal should be submitted to Ece Auffarth, PhD (ece.auffarth@einstein.yu.edu) in the Office of Biotechnology, NO LATER than, May 1st , 2014.   

  

After review of your  non-confidential proposal, Dr. Auffarth will work with you in submitting your non-confidential proposal to the GSK portal.

 

 

 ***ATTENTION MONTEFIORE COMMUNITY!!*** 

Richard Kosman (Director, Office of Business Development at Einstein) will be hosting regularly scheduled "Office Hours" at Montefiore on the second Friday of the month from 9am - 11am in the second floor conference room at 3308 Rochambeau Avenue, Bronx, NY for  "drop-in" office hours. During these hours, Richard will be available to discuss the Technology Commercialization Initiative at Montefiore and how it relates to your research.  If you would like to set up a specific time with Richard, please contact the office to set an appointment.   

            **********************************************************  

This site will serve as a communication tool for the faculty and staff of Albert Einstein College of Medicine, as well as our industry partners. The office of biotechnology serves as the technology transfer office of the college, facilitating the licensing of college technology to industry and research collaborations between industry and faculty. The office of business development serves to further enhance the value of the college's research, clinical and intellectual property assets by proactively collaborating with the commercial, governmental, financial and entrepreneurial communities in novel initiatives. Together, the offices work in partnership and build upon each other’s strengths, in order to fulfill the mission of assisting the translation of basic research advances made at Einstein into clinical applications that can benefit the public. 

The Albert Einstein College of Medicine retains assignment of all patents granted to its faculty. The college, through its Patent Committee, provides a mechanism for internal peer review and encouragement for its faculty to pursue patenting of technologies that are novel and have clear-cut, practical applications in biology and medicine. These applications have broad utility in biotechnology, clinical diagnostics and pharmaceutical medicine. The college is interested in promoting industry-sponsored research on our campus and the commercial development of products derived from our research activities.  

Information about our policies on patenting and working with industrial partners can be found on this site, as well as technologies available for licensing and our contact information. We look forward to working with you.

 

Contact Us

 

Offices of Biotechnology and Business Development
1300 Morris Park Avenue
Room 908, Belfer Building
Bronx, NY 10461
Tel: 718.430.3357
Fax: 718.430.8938
biotech@einstein.yu.edu 

 

 
Click here to log in